Monthly Archives: May 2010
A Big Thank You to the Worldwide ERC Foundation!
Each year, the Ovarian Cancer National Alliance receives generous donations from community-hosted fundraising events. From jewelry and bake sales to walks and bike marathons, our supporters significantly make an impact and help us to advance the interests of women with … Continue reading
Posted in Blog Leave a comment
Denise Archuleta
Missed diagnosis equals missed opportunity. It is now 10 months since my total abdominal hysterectomy for Stage IIIC ovarian cancer. I completed 6 months of harsh chemotherapy and now resume my battles with rheumatoid arthritis. I am 45 years old … Continue reading
Posted in Personal stories Leave a comment
Suzanne: Jonesberg, MO
The person I am writing about was courageous, thoughtful, loving, funny (you could NEVER forget her laugh) brave, an avid quilter, Harley rider, Registered Nurse, mother, sister, daughter, and grandmother and she was my MOM. March 1, 2009 she passed … Continue reading
Posted in Personal stories Leave a comment
A Ray of Hope for Ovarian Cancer Research
On May 14th, Ray Romano, Craig Schulman, Orfeh and other well known celebs gathered in New York City for a night of Vegas-style comedy and charity to benefit the Sass Foundation. Produced by our very own Linda John, this star-studded … Continue reading
Posted in Blog Leave a comment
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
Purpose This randomized, multicenter, phase III noninferiority trial was designed to test the efficacy and safety of the combination of pegylated liposomal doxorubicin (PLD) with carboplatin (CD) compared with standard carboplatin and paclitaxel (CP) in patients with platinum-sensitive relapsed/recurrent ovarian … Continue reading
Action is Teal Policy Update
The Alliance Provides Star Witness to Congressional Panel Deliberating Increased Ovarian Cancer Research Funding On May 20th, the House of Representatives held a hearing on funding for the Department of Defense’s Congressionally Directed Medical Research Programs, including the Ovarian Cancer … Continue reading
Posted in Blog Leave a comment
Allergy sufferers less likely to get cancer
Turns out cancer may be something to sneeze at. Allergy sufferers are much less likely to get cancer than people who aren’t tormented by runny noses, itchy eyes and coughs, according to a series of surprising new scientific studies. Texas … Continue reading
Ovarian Cancer National Alliance Comment on Screening Study
Sunday, June 6, a study will be presented to the American Society of Clinical Oncologists regarding ovarian cancer screening. The study, Authored by Karen Lu, followed more than 3,000 women for eight years, measuring their CA-125 levels annually. These women … Continue reading
Cancer victim wins suit
A jury of six in Waterbury Superior Court on Wednesday awarded $4 million to a New Milford woman and $1 million to her husband for negligence caused by her doctor for failing to recommend the removal of her ovaries before … Continue reading
Karen Mason testifies at the Capitol
The Ovarian Cancer National Alliance Testifies on Capitol Hill On May 20th, Karen Mason represented the Ovarian Cancer National Alliance in testifying before the House Appropriations Subcommittee on Defense in requesting $30 million for the Department of Defense Ovarian Cancer … Continue reading
Role of PET/CT in Ovarian Cancer
OBJECTIVE. The purpose of this article is to review the role of FDG PET/CT in ovarian cancer, which is the leading cause of death among gynecologic cancers. CONCLUSION. FDG PET/CT can significantly modify the assessment of the extent of primary … Continue reading
Can a Multimarker Assay Improve Screening for Ovarian Cancer?
Almost three quarters of ovarian cancer cases are diagnosed at advanced stages, making this disease the most lethal gynecologic malignancy in U.S. women. Using sera from a total of 1400 healthy women, and women with early- and late-stage ovarian cancer, … Continue reading
